You are here

Article Text

Article menu
Download PDFPDF
Update on biologicals
Update on rituximab

https://doi.org/10.1136/ard.2005.042648

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • ↵‡ Rheumatoid arthritis also has RCT supported data for efficacy

    • Dr Eisenberg’s work with Rituxan and systemic lupus erythematosus has been supported by Genentech, Inc., Biogen Idec, the NIH, Alliance for Lupus Research (Arthritis Foundation), and the Lupus Foundation.

    • Competing interests: Dr Eisenberg has consulted with Genentech, Inc., and Biogen Idec as part of this project.